Zobrazeno 1 - 10
of 357
pro vyhledávání: '"A L Dewar"'
Autor:
Katherine D. Wick, Lianne Siegel, James D. Neaton, Cathryn Oldmixon, Jens Lundgren, Robin L. Dewar, H. Clifford Lane, B. Taylor Thompson, Michael A. Matthay, on behalf of the ACTIV-3/TICO study group
Publikováno v:
JCI Insight, Vol 7, Iss 9 (2022)
Background The value of the soluble receptor for advanced glycation end-products (sRAGE) as a biomarker in COVID-19 is not well understood. We tested the association between plasma sRAGE and illness severity, viral burden, and clinical outcomes in ho
Externí odkaz:
https://doaj.org/article/26c62bcafd5c4b4fbf5c325455749c75
Autor:
Irini Sereti, Kathryn Shaw-Saliba, Lori E. Dodd, Robin L. Dewar, Sylvain Laverdure, Shawn Brown, Olivier Tshiani Mbaya, Jean Jacques Muyembe Tamfum, Placide Mblala-Kingebeni, Ydrissa Sow, Esther Akpa, Mory Cherif Haidara, Karine Fouth Tchos, Abdoul Habib Beavogui, Aaron Neal, Dona Arlinda, Dewi Lokida, Louis Grue, Mary Smolskis, Laura A. McNay, Dehkontee Gayedyu-Dennis, Guillermo M. Ruiz-Palacios, Abelardo Montenegro-Liendo, Moctar Tounkara, Seydou Samake, Ganbolor Jargalsaikhan, Delgersaikhan Zulkhuu, Shera Weyers, Tyler Bonnett, Gail E. Potter, Randy Stevens, Adam Rupert, Jamila Aboulhab, Jean-Luc Biampata, Alexandre Delamo, Bienvenu Salim Camara, Herman Kosasih Indonesia, Muhammad Karyana, James T. Duworko, Justino Regalado-Pineda, Paola del Carmen Guerra-de-Blas, Seydou Doumbia, Djeneba Dabitao, Naranjargal Dashdorj, Naranbaatar Dashdorj, Kevin Newell, Alyson Francis, Kevin Rubenstein, Victoria Bera, Iman Gulati, Ratna Sardana, Monica Millard, Renee Ridzon, Sally Hunsberger
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines b
Externí odkaz:
https://doaj.org/article/35221598c0804d42bd34c327097f7182
Autor:
Brian J. Morrison, Nicholas J. Martin, Tauseef Rehman, Dan Ewing, Robin L. Dewar, Julia Metcalf, Peifang Sun, John Beigel, Thomas C. Luke, Kanakatte Raviprakash
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background The hemagglutination-inhibition (HAI) assay is a critical component for measurement of immunogenicity in influenza vaccine development. It is unknown if the results can be influenced by sample type and anticoagulants. The purpose
Externí odkaz:
https://doaj.org/article/6a34611baed8484a89d87b64d78d26bf
Autor:
Jun Yang, Ming Hao, Muhammad A. Khan, Muhammad T. Rehman, Helene C. Highbarger, Qian Chen, Suranjana Goswami, Brad T. Sherman, Catherine A. Rehm, Robin L. Dewar, Weizhong Chang, Tomozumi Imamichi
Publikováno v:
Viruses, Vol 13, Iss 11, p 2331 (2021)
We have recently reported that a recombinant HIV-1NL4.3 containing Met-to-Ile change at codon 50 of integrase (IN) (IN:M50I) exhibits suppression of the virus release below 0.5% of WT HIV, and the released viral particles are replication-incompetent
Externí odkaz:
https://doaj.org/article/d3ccaabb87b0429cb3c47bc2cede4361
Autor:
Brian P Epling, Joseph M Rocco, Kristin L Boswell, Elizabeth Laidlaw, Frances Galindo, Anela Kellogg, Sanchita Das, Allison Roder, Elodie Ghedin, Allie Kreitman, Robin L Dewar, Sophie E M Kelly, Heather Kalish, Tauseef Rehman, Jeroen Highbarger, Adam Rupert, Gregory Kocher, Michael R Holbrook, Andrea Lisco, Maura Manion, Richard A Koup, Irini Sereti
Publikováno v:
Clinical Infectious Diseases. 76:573-581
Background Nirmatrelvir/ritonavir, the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) protease inhibitor, reduces the risk of hospitalization and death by coronavirus disease 2019 (COVID-19) but has been associated with symptomati
Autor:
Xiaoli Jiao, Hiromi Imamichi, Brad T Sherman, Rishub Nahar, Robin L Dewar, H Clifford Lane, Tomozumi Imamichi, Weizhong Chang
Publikováno v:
Bioinformatics
Motivation The existence of quasispecies in the viral population causes difficulties for disease prevention and treatment. High-throughput sequencing provides opportunity to determine rare quasispecies and long sequencing reads covering full genomes
Autor:
Kanal Singh, Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin L Dewar, Sylvain Laverdure, Helene Highbarger, Perrine Lallemand, Meei-Li Huang, Keith R Jerome, Reigran Sampoleo, Margaret Mills, Danielle P Porter, Kavita Juneja, Alexander L Greninger, H Clifford Lane, John H Beigel, Lori E Dodd
Publikováno v:
Open Forum Infectious Diseases. 9
Background ACTT-1 demonstrated clinical efficacy of remdesivir (RDV) in hospitalized patients with COVID-19; subgroup analyses suggested those most likely to benefit presented with milder clinical illness. To further clarify what subsets of hospitali
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19:A Randomized Controlled Trial
Autor:
Christina, Barkauskas, Eleftherios, Mylonakis, Garyfallia, Poulakou, Barnaby E, Young, David M, Vock, Lianne, Siegel, Nicole, Engen, Greg, Grandits, Nilima R, Mosaly, Andrew M, Vekstein, Ralph, Rogers, Fadi, Shehadeh, Matthew, Kaczynski, Evangelia K, Mylona, Konstantinos N, Syrigos, Vasiliki, Rapti, David C, Lye, Diong Shiau, Hui, Lindsay, Leither, Kirk U, Knowlton, Mamta K, Jain, Rubria, Marines-Price, Alice, Osuji, J Scott, Overcash, Ioannis, Kalomenidis, Zafeiria, Barmparessou, Michael, Waters, Karla, Zepeda, Peter, Chen, Sam, Torbati, Francis, Kiweewa, Nicholus, Sebudde, Eyad, Almasri, Alyssa, Hughes, Sanjay R, Bhagani, Alison, Rodger, Uriel, Sandkovsky, Robert L, Gottlieb, Eriobu, Nnakelu, Barbara, Trautner, Vidya, Menon, Joseph, Lutaakome, Michael, Matthay, Philip, Robinson, Konstantinos, Protopapas, Nikolaos, Koulouris, Ivan, Kimuli, Amiran, Baduashvili, Dominique L, Braun, Huldrych F, Günthard, Srikanth, Ramachandruni, Robert, Kidega, Kami, Kim, Timothy J, Hatlen, Andrew N, Phillips, Daniel D, Murray, Tomas O, Jensen, Maria L, Padilla, Evan X, Accardi, Katy, Shaw-Saliba, Robin L, Dewar, Marc, Teitelbaum, Ven, Natarajan, Sylvain, Laverdure, Helene C, Highbarger, M Tauseef, Rehman, Susan, Vogel, David, Vallée, Page, Crew, Negin, Atri, Adam J, Schechner, Sarah, Pett, Fleur, Hudson, Jonathan, Badrock, Giota, Touloumi, Samuel M, Brown, Wesley H, Self, Crystal M, North, Adit A, Ginde, Christina C, Chang, Anthony, Kelleher, Stephanie, Nagy-Agren, Shikha, Vasudeva, David, Looney, Hien H, Nguyen, Adriana, Sánchez, Amy C, Weintrob, Birgit, Grund, Shweta, Sharma, Cavan S, Reilly, Roger, Paredes, Agnieszka, Bednarska, Norman P, Gerry, Abdel G, Babiker, Victoria J, Davey, Annetine C, Gelijns, Elizabeth S, Higgs, Virginia, Kan, Gail, Matthews, B Taylor, Thompson, Philippe, Legenne, Richa, Chandra, H Clifford, Lane, James D, Neaton, Richard, Williams
Publikováno v:
ACTIV-3/TICO Study Group*, Nielsen, H, Thisted, R K, Petersen, K T & Juhl, M R 2022, ' Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 9, pp. 1266-1274 . https://doi.org/10.7326/M22-1503
BACKGROUND: Ensovibep (MP0420) is a designed ankyrin repeat protein, a novel class of engineered proteins, under investigation as a treatment of SARS-CoV-2 infection. OBJECTIVE: To investigate if ensovibep, in addition to remdesivir and other standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d142eddc0f692abd7c33d99b51bb4e
https://vbn.aau.dk/da/publications/828dfc6c-d4d0-47b8-a749-9cc4901459a8
https://vbn.aau.dk/da/publications/828dfc6c-d4d0-47b8-a749-9cc4901459a8
Autor:
Angela J, Rogers, Deborah, Wentworth, Andrew, Phillips, Katy, Shaw-Saliba, Robin L, Dewar, Neil R, Aggarwal, Abdel G, Babiker, Weizhong, Chang, Nila J, Dharan, Victoria J, Davey, Elizabeth S, Higgs, Norman, Gerry, Adit A, Ginde, J W Awori, Hayanga, Helene, Highbarger, Jeroen L, Highbarger, Mamta K, Jain, Virginia, Kan, Kami, Kim, Perrine, Lallemand, Bradley G, Leshnower, Joseph K, Lutaakome, Gail, Matthews, Ahmad, Mourad, Eleftherios, Mylonakis, Ven, Natarajan, Maria L, Padilla, Lavannya M, Pandit, Roger, Paredes, Sarah, Pett, Srikanth, Ramachandruni, M Tauseef, Rehman, Brad T, Sherman, D Clark, Files, Samuel M, Brown, Michael A, Matthay, B Taylor, Thompson, James D, Neaton, H Clifford, Lane, Richard, Williams
Publikováno v:
ACTIV-3/TICO Study Group*, Nielsen, H, Thisted, R K, Petersen, K T & Juhl, M R 2022, ' The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 ', Annals of Internal Medicine, vol. 175, no. 10, pp. 1401-1410 . https://doi.org/10.7326/M22-0924
Background: Levels of plasma SARS-CoV-2 nucleocapsid (N) antigen may be an important biomarker in patients with COVID-19 and enhance our understanding of the pathogenesis of COVID-19. Objective: To evaluate whether levels of plasma antigen can predic
Autor:
Djeneba Dabitao, Kathryn Shaw-Saliba, Drissa S. Konate, Helene C. Highbarger, Perrine Lallemand, Ibrahim Sanogo, Tauseef Rehman, Mamadou Wague, Nadie Coulibaly, Bourahima Kone, Bocar Baya, Seidina A.S. Diakite, Seydou Samake, Esther Akpa, Moctar Tounkara, Sylvain Laverdure, Seydou Doumbia, H. Clifford Lane, Mahamadou Diakite, Robin L. Dewar
Publikováno v:
Journal of Immunological Methods. 517:113488